Secondly, the intervention compliance was self-reported, but we believe the low initial HbA1c (suggesting excellent compliance to diabetes regimen) and the decrease in the insulin dose throughout the LCD period (data shown elsewhere) [12] allow us to presume high compliance of the study participants. This evidence concerns the gene INS and diabetes mellitus.